OBJECTIVE: Hypoglycemia increases the risk of adverse neurological outcomes in neonates. Adequate glucose monitoring requires repetitive and painful blood sampling. We aimed to evaluate the feasibility and accuracy of a continuous glucose monitoring system (CGMS) using factory-calibrated sensors to improve glucose monitoring and decrease the frequency of blood samples in neonates. MATERIAL AND METHODS: A methodological study was conducted to investigate a correlation of CGMS values with blood glucose measurements. RESULTS: Factory-calibrated CGMS sensors were placed on 21 infants at risk of hypoglycemia after delivery. CGMS values were compared with blood glucose concentrations. Thirty-seven pairs of CGMS and blood glucose values were obtained. There was a good correlation between CGMS and blood glucose values (R=0.67, p<0.01) with a mean difference (2 standard deviations) of 9.78 (-24.68 to 44.25) mg/dL. The mean differences at <3 hours and ≥3 hours after sensor placement were 17.35 (-4.54 to 39.21) mg/dL and 0.88 (-37.62 to 39.38) mg/dL, respectively. CGMS values were significantly higher than blood glucose concentration at <3 hours after sensor placement (p<0.01), whereas no significant differences in glucose values were observed between the CGMS and blood glucose values at ≥3 hours after sensor placement (p=0.852). CONCLUSION: The factory-calibrated CGMS was a safe and feasible modality for glucose monitoring. However, it has a tendency to overestimate the blood glucose concentrations. Therefore, this system should be used cautiously for neonates at risk of hypoglycemia, especially within 3 hours after sensor placement.
OBJECTIVE: Hypoglycemia increases the risk of adverse neurological outcomes in neonates. Adequate glucose monitoring requires repetitive and painful blood sampling. We aimed to evaluate the feasibility and accuracy of a continuous glucose monitoring system (CGMS) using factory-calibrated sensors to improve glucose monitoring and decrease the frequency of blood samples in neonates. MATERIAL AND METHODS: A methodological study was conducted to investigate a correlation of CGMS values with blood glucose measurements. RESULTS: Factory-calibrated CGMS sensors were placed on 21 infants at risk of hypoglycemia after delivery. CGMS values were compared with blood glucose concentrations. Thirty-seven pairs of CGMS and blood glucose values were obtained. There was a good correlation between CGMS and blood glucose values (R=0.67, p<0.01) with a mean difference (2 standard deviations) of 9.78 (-24.68 to 44.25) mg/dL. The mean differences at <3 hours and ≥3 hours after sensor placement were 17.35 (-4.54 to 39.21) mg/dL and 0.88 (-37.62 to 39.38) mg/dL, respectively. CGMS values were significantly higher than blood glucose concentration at <3 hours after sensor placement (p<0.01), whereas no significant differences in glucose values were observed between the CGMS and blood glucose values at ≥3 hours after sensor placement (p=0.852). CONCLUSION: The factory-calibrated CGMS was a safe and feasible modality for glucose monitoring. However, it has a tendency to overestimate the blood glucose concentrations. Therefore, this system should be used cautiously for neonates at risk of hypoglycemia, especially within 3 hours after sensor placement.
Authors: T M Gross; B W Bode; D Einhorn; D M Kayne; J H Reed; N H White; J J Mastrototaro Journal: Diabetes Technol Ther Date: 2000 Impact factor: 6.118
Authors: K Beardsall; A L Ogilvy-Stuart; J Ahluwalia; M Thompson; D B Dunger Journal: Arch Dis Child Fetal Neonatal Ed Date: 2005-07 Impact factor: 5.747
Authors: Jeffrey R Kaiser; Shasha Bai; Neal Gibson; Greg Holland; Tsai Mei Lin; Christopher J Swearingen; Jennifer K Mehl; Nahed O ElHassan Journal: JAMA Pediatr Date: 2015-10 Impact factor: 16.193
Authors: Guy G Massa; Inge Gys; Anniek Op 't Eyndt; Esmiralda Bevilacqua; Anne Wijnands; Peter Declercq; Renate Zeevaert Journal: Horm Res Paediatr Date: 2018-03-27 Impact factor: 2.852
Authors: Andreas Liebl; Helmut R Henrichs; Lutz Heinemann; Guido Freckmann; Eberhard Biermann; Andreas Thomas Journal: J Diabetes Sci Technol Date: 2013-03-01
Authors: Ruth E Grunau; Michael F Whitfield; Julianne Petrie-Thomas; Anne R Synnes; Ivan L Cepeda; Adi Keidar; Marilyn Rogers; Margot Mackay; Philippa Hubber-Richard; Debra Johannesen Journal: Pain Date: 2009-05 Impact factor: 6.961